<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04933513</url>
  </required_header>
  <id_info>
    <org_study_id>2020PI179</org_study_id>
    <nct_id>NCT04933513</nct_id>
  </id_info>
  <brief_title>Development and Validation of a Scale Measuring Preoperative Expectations in Parkinson's Disease</brief_title>
  <official_title>Development and Validation of a French Scale Measuring Preoperative Expectations of Parkinson's Disease Patients Candidate to Deep Brain Stimulation : the DBS-PS (Deep Brain Stimulation Perception Scale)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Subthalamic nucleus deep brain stimulation (STN-DBS) has become a choice treatment for&#xD;
      fluctuating Parkinson's disease (PD) patients, inducing remarkable improvement in motor&#xD;
      symptoms. However, as PD is a complex neuropsychiatric disease, it has been hypothesized that&#xD;
      in some patients, non-motor features, i.e. dysfunctional expectations for the result of&#xD;
      neurosurgery, could interfere with postoperative result of DBS, even in case of motor&#xD;
      improvement. Recent literature highlights the necessity to take these preoperative&#xD;
      expectations into account, but to our knowledge, no specific scale investigating these&#xD;
      cognitions in this PD-specific condition is available. So, the investigators developped the&#xD;
      DBS-PS, a self-scale constructed to measure preoperative expectations for DBS, with 11&#xD;
      questions and visuo-analogical responses (1 to 10), theorically divided in three domains&#xD;
      investigating the expectations concerning symptoms of PD, postoperative social-life and&#xD;
      leisures, and postoperative familial and marital sphere. The investigators would like to&#xD;
      validate this new-developped scale in the preoperative subthalamic nucleus deep brain&#xD;
      stimulation population through patients recruited in the Predistim study, whereas the&#xD;
      investigators did not recruite sufficiently patients through the PsyParkinson study, the one&#xD;
      in which the DBS-PS scale was developed. The DBS-PS constitutes an interesting basis for the&#xD;
      consideration of these cognitive and affective factors in preoperative PD patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 30, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Validation of the Deep-brain stimulation - perception scale (DBS-PS scale)</measure>
    <time_frame>during the inclusion/baseline period of Predistim study</time_frame>
    <description>Deep Brain Stimulation-Perception Scale completed by Parkinson's disease patients enrolled in the Predistim study; minimum scale score 0 - maximum scale score 50, for each sub-scores (3 dimensions) ; a higher score corresponding to higher expectations in the dimension, and a lower score coresponding to lower expectations in the dimension</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>preoperative Parkinson' disease</arm_group_label>
    <description>pre DBS parkinson's disease patients responding to the DBS-PS scale preoperatively</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>pre DBS patients responding to the DBS-PS scale</intervention_name>
    <description>we propose to parkinson's disease patients selected for subthalamic deep brain stimulation to complete the DBS-PS scale preoperatively</description>
    <arm_group_label>preoperative Parkinson' disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        - Parkinson's disease patients selected for STN DBS and participating to the Predistim&#xD;
        study&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Parkinson's disease patients included in the Predistim study and having completed the&#xD;
             DBS-PS scale during the preoperative phase&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Parkinson's disease patients not included in the Predistim study or not having&#xD;
             completed the DBS-PS scale during the preoperative phase&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU de Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Mylene MEYER, PhD</last_name>
      <phone>0383859661</phone>
      <email>my.meyer@chru-nancy.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 8, 2021</study_first_submitted>
  <study_first_submitted_qc>June 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2021</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Central Hospital, Nancy, France</investigator_affiliation>
    <investigator_full_name>Mme Mylène MEYER</investigator_full_name>
    <investigator_title>psychologist, PhD</investigator_title>
  </responsible_party>
  <keyword>deep brain stimulation</keyword>
  <keyword>preoperative expectations</keyword>
  <keyword>DBS-PS</keyword>
  <keyword>validation</keyword>
  <keyword>Parkinson's disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

